Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ELI LILLY AND COMPANY Hits Price Target Forecast with 20.73% Profit on QuantWave

May 01, 2023
On March 24, 2023, QuantWave, the automated forecasting platform, issued a long signal for ELI LILLY AND COMPANY stock when it was trading at 330.51 $. The prediction proved to be accurate as on May 1, 2023, the stock reached the target price of 399.03 $, resulting in a profit of 20.73%.

This successful forecast for ELI LILLY AND COMPANY demonstrates the effectiveness of QuantWave's analytics in identifying profitable trading opportunities. The market analysis indicates that the stock experienced a positive movement during this period, likely driven by strong financial performance, positive news developments, and overall market sentiment.

QuantWave's ability to deliver precise forecasts for ELI LILLY AND COMPANY reflects the platform's sophisticated algorithms and advanced technical analysis capabilities. Investors and traders who utilize QuantWave's predictions have the potential to capitalize on market movements and achieve substantial profits.

For those seeking to leverage QuantWave's forecasting system for their investment strategy, exploring QuantSchool's educational resources is highly recommended. QuantSchool offers a professional investment framework that outlines the key principles for generating consistent income using the QuantWave platform.

Overall, the achievement of the price target forecast for ELI LILLY AND COMPANY underscores the value of QuantWave's predictive analytics in navigating the dynamic and competitive financial markets.
If you want to leave a comment, then you need Login or Register





Other data for LLY

Related data

LLYJuly 20, 2025Strong Q2 Forecast for ELI LILLY AND COMPANY by J.P. Morgan  ~1 min.

According to J.P. Morgan, Eli Lilly and Company is expected to have a strong second quarter performance. The pharmaceutical giant has been receiving positive attention from investors and analysts alike....

LLYMarch 22, 2025Eli Lilly and Company LLY: Leading the Way in Pharmaceutical Innovation  ~2 min.

Eli Lilly and Company (LLY) continues to make waves in the pharmaceutical industry with its innovative and groundbreaking therapies....

LLYMarch 19, 2025Eli Lilly and Company LLY Surges After Breakthrough BRAVE-AA-PEDS Study Results  ~2 min.

Eli Lilly and Company (LLY) has recently made a significant breakthrough in its BRAVE-AA-PEDS study, resulting in a surge of investor attention and market gains....

LLYMarch 18, 2025Eli Lilly and Company: A Promising Investment in the Pharma Industry  ~1 min.

Eli Lilly and Company (LLY) has been making waves in the pharmaceutical industry with its innovative products and strong performance....

LLYMarch 17, 2025Eli Lilly and Company's Groundbreaking Discovery Revolutionizes Pharma Industry  ~2 min.

Eli Lilly and Company, a renowned pharmaceutical giant, has recently made a groundbreaking discovery that is set to revolutionize the entire industry....

LLYMarch 16, 2025Is Eli Lilly and Company LLY Set to Revolutionize the Pharma Industry?  ~2 min.

Eli Lilly and Company (LLY) has been making headlines recently with its groundbreaking research and innovative products....

LLYMarch 14, 2025Eli Lilly and Company Reports Promising Results in Hair Regrowth Study  ~1 min.

Eli Lilly and Company (LLY) recently announced the positive outcome of their Phase 3 clinical trial for baricitinib, a drug aimed at treating severe alopecia areata in adolescents....

LLYFebruary 28, 2025Lilly plans to more than double U.S. manufacturing investment since 2020 exceeding 50 billion  ~1 min.

Eli Lilly and Company (LLY) is set to significantly increase its manufacturing investment in the United States, surpassing a staggering 50 billion since 2020....

LLYFebruary 27, 2025Eli Lilly and Company Acquires Organovos FXR Program in IBD Treatment Development  ~1 min.

Eli Lilly and Company has recently made headlines with its acquisition of Organovos FXR Program, a significant step towards advancing treatment options for Inflammatory Bowel Disease (IBD)....

LLYFebruary 26, 2025ELI LILLY AND COMPANY Launches Additional Zepbound Vial Doses and Offers New Savings  ~2 min.

ELI LILLY AND COMPANY has recently announced the launch of additional Zepbound vial doses, as well as new savings for self-pay patients....

NFLXJanuary 23, 2025NETFLIX, INC. Stock Hits Price Target Forecast with 51.75% Profit: QuantWave's Success Story  ~2 min.

QuantWave, the leading automated forecasting platform, has once again demonstrated its accuracy with the successful prediction of NETFLIX, INC. stock movement....

GOOGLJuly 26, 2023ALPHABET INC. Hits Price Target Forecast with 18.88% Profit Margin  ~2 min.

ALPHABET INC., the parent company of Google, has successfully reached the price target forecasted by QuantWave on 2022-07-01 with a predicted long position. The stock was trading at 108....

SOOctober 1, 2024THE SOUTHERN COMPANY Hits Price Target Forecast with 16.73% Profit  ~2 min.

QuantWave's forecast for THE SOUTHERN COMPANY has proven to be exceptionally accurate, with the stock hitting the predicted target price with a significant 16.73% profit margin....

MSFTJuly 17, 2025QuantWave Hits Bullseye with Microsoft Stock Forecast, Achieving 19.16% Profit  ~2 min.

QuantWave, the leading automated forecasting platform, has once again demonstrated its predictive prowess with an astonishing 19.16% profit on its recent Microsoft Corporation stock forecast....

NVDAFebruary 22, 2024QuantWave Successfully Achieves 39.3% Profit with NVIDIA CORPORATION Forecast  ~1 min.

In a recent triumph for QuantWave, the automated forecasting platform accurately predicted a long position for NVIDIA CORPORATION's stock on January 16, 2024, when it was trading at 56.36 $....